Application 215019

Type
NDA
Sponsor
EDENBRIDGE PHARMS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001DARTISLA ODTGLYCOPYRROLATETABLET;ORALLY DISINTEGRATING1.7MGNoNo
002DARTISLA ODTGLYCOPYRROLATETABLET, ORALLY DISINTEGRATING;ORAL0.85MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
82111-518DARTISLA ODTGlycopyrrolate Orally Disintegrating TabletsEdenbridge Pharmaceuticals LLC.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
76026SUPPL 2023-11-01
71635ORIG2022-07-27
69707ORIG2021-12-21
69626ORIG2021-12-17